Literature DB >> 10669754

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.

H Li1, C Leo, J Zhu, X Wu, J O'Neil, E J Park, J D Chen.   

Abstract

PML fuses with retinoic acid receptor alpha (RARalpha) in the t(15;17) translocation that causes acute promyelocytic leukemia (APL). In addition to localizing diffusely throughout the nucleoplasm, PML mainly resides in discrete nuclear structures known as PML oncogenic domains (PODs), which are disrupted in APL and spinocellular ataxia cells. We isolated the Fas-binding protein Daxx as a PML-interacting protein in a yeast two-hybrid screen. Biochemical and immunofluorescence analyses reveal that Daxx is a nuclear protein that interacts and colocalizes with PML in the PODs. Reporter gene assay shows that Daxx drastically represses basal transcription, likely by recruiting histone deacetylases. PML, but not its oncogenic fusion PML-RARalpha, inhibits the repressor function of Daxx. In addition, SUMO-1 modification of PML is required for sequestration of Daxx to the PODs and for efficient inhibition of Daxx-mediated transcriptional repression. Consistently, Daxx is found at condensed chromatin in cells that lack PML. These data suggest that Daxx is a novel nuclear protein bearing transcriptional repressor activity that may be regulated by interaction with PML.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669754      PMCID: PMC85360          DOI: 10.1128/MCB.20.5.1784-1796.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

Authors:  L Z He; F Guidez; C Tribioli; D Peruzzi; M Ruthardt; A Zelent; P P Pandolfi
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Role of PML in cell growth and the retinoic acid pathway.

Authors:  Z G Wang; L Delva; M Gaboli; R Rivi; M Giorgio; C Cordon-Cardo; F Grosveld; P P Pandolfi
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

3.  Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.

Authors:  F Grignani; S De Matteis; C Nervi; L Tomassoni; V Gelmetti; M Cioce; M Fanelli; M Ruthardt; F F Ferrara; I Zamir; C Seiser; F Grignani; M A Lazar; S Minucci; P G Pelicci
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  Role of the histone deacetylase complex in acute promyelocytic leukaemia.

Authors:  R J Lin; L Nagy; S Inoue; W Shao; W H Miller; R M Evans
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.

Authors:  Y Shen; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

Authors:  F Guidez; S Ivins; J Zhu; M Söderström; S Waxman; A Zelent
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

7.  Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.

Authors:  S Müller; M J Matunis; A Dejean
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

8.  The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Authors:  L Szekely; K Pokrovskaja; W Q Jiang; H de The; N Ringertz; G Klein
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.

Authors:  T Sternsdorf; K Jensen; H Will
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

10.  The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.

Authors:  M H Koken; F Puvion-Dutilleul; M C Guillemin; A Viron; G Linares-Cruz; N Stuurman; L de Jong; C Szostecki; F Calvo; C Chomienne
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  122 in total

1.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

2.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Authors:  Yutong Xue; Richard Gibbons; Zhijiang Yan; Dafeng Yang; Tarra L McDowell; Salvatore Sechi; Jun Qin; Sharleen Zhou; Doug Higgs; Weidong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

4.  SUMO modified proteins localize to the XY body of pachytene spermatocytes.

Authors:  Richard S Rogers; Amy Inselman; Mary Ann Handel; Michael J Matunis
Journal:  Chromosoma       Date:  2004-09-03       Impact factor: 4.316

Review 5.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

6.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

7.  A quantitative inventory of yeast P body proteins reveals principles of composition and specificity.

Authors:  Wenmin Xing; Denise Muhlrad; Roy Parker; Michael K Rosen
Journal:  Elife       Date:  2020-06-19       Impact factor: 8.140

8.  Negative modulation of androgen receptor transcriptional activity by Daxx.

Authors:  Ding-Yen Lin; Hsin-I Fang; Ai-Hong Ma; Yen-Sung Huang; Yeong-Shiau Pu; Guido Jenster; Hsing-Jien Kung; Hsiu-Ming Shih
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Daxx silencing sensitizes cells to multiple apoptotic pathways.

Authors:  Liuh-Yow Chen; J Don Chen
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.